Rigel Pharmaceuticals, Inc. will report its fourth quarter and full year 2025 financial results after market close on March 3, 2026. The results will be released after market close. Rigel will host a live conference call and webcast on March 3, 2026 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss the results and provide a business update, with Rigel senior management participating. The webcast (and slides) can be accessed via the Investor Relations section of https://www.rigel.com.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rigel Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202602240805PR_NEWS_USPR_____SF93852) on February 24, 2026, and is solely responsible for the information contained therein.
Comments